BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27232880)

  • 1. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
    Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
    PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p.
    Wang C; Zou H; Chen A; Yang H; Yu X; Yu X; Wang Y
    J Biochem; 2020 Jun; 167(6):565-575. PubMed ID: 31943014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA plasmacytoma variant translocation 1 gene promotes the development of cervical cancer via the NF‑κB pathway.
    Wang C; Zou H; Yang H; Wang L; Chu H; Jiao J; Wang Y; Chen A
    Mol Med Rep; 2019 Sep; 20(3):2433-2440. PubMed ID: 31322217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Feng LL; Shen FR; Zhou JH; Chen YG
    Gene; 2019 May; 696():105-112. PubMed ID: 30738960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA PVT1 Facilitates Cervical Cancer Progression via Negative Regulating of miR-424.
    Gao YL; Zhao ZS; Zhang MY; Han LJ; Dong YJ; Xu B
    Oncol Res; 2017 Sep; 25(8):1391-1398. PubMed ID: 28276314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1.
    Shen SN; Li K; Liu Y; Yang CL; He CY; Wang HR
    Mol Oncol; 2019 Dec; 13(12):2554-2573. PubMed ID: 31369196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
    Yang J; Li C; Mudd A; Gu X
    Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
    Yang Q; Yu Y; Sun Z; Pan Y
    Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells.
    Shen CJ; Cheng YM; Wang CL
    J Drug Target; 2017 Aug; 25(7):637-644. PubMed ID: 28296507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
    Zhang S; Zhang G; Liu J
    APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b.
    Zhang R; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Liu Y
    Med Sci Monit; 2018 Dec; 24():8685-8692. PubMed ID: 30504754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression.
    Zhang Y; Tan Y; Wang H; Xu M; Xu L
    Med Sci Monit; 2019 Oct; 25():7652-7659. PubMed ID: 31604907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2.
    Yang A; Wang H; Yang X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Long Noncoding RNA Plasmacytoma Variant Translocation 1 with Antisense Locked Nucleic Acid GapmeRs Exerts Tumor-Suppressive Functions in Human Acute Erythroleukemia Cells Through Downregulation of
    Salehi M; Sharifi M; Bagheri M
    Cancer Biother Radiopharm; 2019 Aug; 34(6):371-379. PubMed ID: 30141968
    [No Abstract]   [Full Text] [Related]  

  • 19. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
    Wu XZ; Cui HP; Lv HJ; Feng L
    Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma.
    He Y; Jing Y; Wei F; Tang Y; Yang L; Luo J; Yang P; Ni Q; Pang J; Liao Q; Xiong F; Guo C; Xiang B; Li X; Zhou M; Li Y; Xiong W; Zeng Z; Li G
    Cell Death Dis; 2018 Feb; 9(2):235. PubMed ID: 29445147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.